Cas:51541-08-3 ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate manufacturer & supplier

Chemical Name:ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate

CAS.NO:51541-08-3

Synonyms:2-Propenoic acid,2-methyl-,2-oxiranylmethyl ester,polymer with ethene and methyl 2-propenoate;2-Propenoic acid,2-methyl-,oxiranylmethyl ester,polymer with ethene and methyl 2-propenoate;MFCD00217719

Molecular Formula:C₁₃H₂₀O₅

Molecular Weight:256.29500

HS Code:

Physical and Chemical Properties:

Melting point:39ºC(lit.)

Boiling point:189ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:65.13000

Exact Mass:256.13100

LogP:1.65210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-Propenoic acid,2-methyl-,2-oxiranylmethyl ester,polymer with ethene and methyl 2-propenoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00217719 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00217719 Use and application,2-Propenoic acid,2-methyl-,2-oxiranylmethyl ester,polymer with ethene and methyl 2-propenoate technical grade,usp/ep/jp grade.

Related News: The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate supplier Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate vendor Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. ethene,methyl prop-2-enoate,oxiran-2-ylmethyl 2-methylprop-2-enoate factory The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.